20th Anniversary
Membership
- Current Members
Initiatives
Advocacy
About
CRO Forum

ERT Blogpost: FDA Guidance Overview: Assessing Symptoms in Clinical Trials Aimed to Prevent and Treat COVID-19

January 6, 2021 By Natalia Gonzalez

Previous Article

Medidata Blogpost: AI and Advanced Analytics: Delivering Value for Clinical Trials During COVID-19

Next Article

Syneos Health Factsheet: Predicting Landfall: A Dynamic Control Room for Taking on the COVID-19 Landscape

Recent Posts

ACRO Publishes Newest Landscape Survey Results: Risk-Based Quality Management in Clinical Trials
ACRO Expands Decentralized Clinical Trials Toolkit with Release of Change Management Resource
ACRO & TransCelerate Issue a Joint Statement on Considerations while Developing Clinical Study Reports (CSRs)
ACRO Releases Diversity and Inclusion Principles Statement in Support of More Diverse Clinical Trials
OPINION: Keep Our Foot on the Gas for Clinical Trial Diversity

About ACRO

The Association of Clinical Research Organizations (ACRO) and its members collaborate in pursuit of a global regulatory and business environment that fosters efficient, effective & safe clinical research.

Subscribe

Get in Touch

601 New Jersey Ave NW, #350,
Washington DC 20001
info@acrohealth.org
+1 (202) 464-9340

© ACRO 2021